We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5401:TSENIPPON STEEL CORP. Analysis

Data as of 2026-06-12 - not real-time

MYR 1.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Tropicana’s price is trading just above a key support level, with the 20‑day SMA positioned beneath both the 50‑day and 200‑day SMAs, signalling a continued bearish bias. The 14‑day RSI sits in the lower‑mid territory, implying limited momentum but not yet oversold conditions. A modest bullish crossover in the MACD (line above signal) offers a faint upside hint, though the histogram remains thin. The nearest resistance is modestly above the current price, creating a narrow trading range. Volatility over the past month is high, while the beta is slightly negative, suggesting the stock moves somewhat independently of the broader market. The company’s book‑to‑price ratio is well below one, indicating the market values the shares at a discount to net assets.
Fundamentally, the firm reports strong revenue growth but negative profit margins and a trailing EPS that remains in the red. Operating cash flow is negative, and the balance sheet shows a high debt‑to‑equity ratio, raising concerns about financial stability. Free cash flow is modestly positive, offering a thin cushion but not enough to offset the debt burden. The lack of any dividend payout eliminates income‑focused appeal. Given the “Extreme Greed” sentiment in the broader market, investors may be tempted to chase the low price, yet the underlying fundamentals remain weak. Overall, the stock appears undervalued relative to book but carries significant risk, warranting a cautious stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish technical trend with price near support
  • negative earnings and high debt
  • limited upside from MACD crossover

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • revenue growth despite profitability issues
  • price discount to book value
  • still‑negative cash flow and leverage concerns

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • potential for turnaround if cash flow improves
  • valuation cushion from low price‑to‑book
  • persistent financial risk from debt and earnings volatility

Key Metrics & Analysis

Financial Health

Revenue Growth20.50%
Profit Margin-6.93%
ROE-2.27%
ROA0.53%
Debt/Equity59.38
P/B Ratio0.7
Op. Cash FlowMYR-429599008
Free Cash FlowMYR34.8M
Industry P/E33.1

Technical Analysis

TrendBearish
RSI36.4
SupportMYR 0.99
ResistanceMYR 1.12
MA 20MYR 1.07
MA 50MYR 1.15
MA 200MYR 1.18
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.11
Volatility24.63%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.